AVNS
Avanos Medical Inc
25.00$
+0.0%
vs. previous close
Closing price · As of: Jul 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.5% | 17.0% | 7.3% | -4.8% | 16.2% | 13.5% | 32.2% | 15.3% | 3.9% | 7.9% | 15.6% | -6.8% | 5.1% | |
| 6.8% | 6.4% | 6.6% | 6.9% | 6.6% | 6.9% | 6.2% | 5.7% | 5.7% | 5.3% | 5.5% | 5.6% | 5.5% | |
| 2.3% | 2.3% | 2.3% | 2.2% | 2.2% | 1.5% | 2.1% | 2.3% | 2.3% | 2.0% | 0.7% | 2.0% | 1.7% | |
| 39.8% | 0.7% | – | – | – | – | – | – | – | – | – | – | – | |
| -7.9% | 12.0% | -2.0% | -13.5% | 4.8% | 2.2% | 25.1% | 3.2% | -3.9% | -1.6% | 13.5% | -17.2% | -2.3% | |
| 2.4% | 2.3% | 3.4% | 2.5% | 3.4% | 1.8% | 2.7% | 4.0% | 6.3% | 3.9% | 3.8% | 2.4% | 4.1% | |
| -3.8% | -28.5% | 46.7% | -1.2% | -3.4% | -7.0% | -4.2% | -5.4% | -7.5% | -17.7% | -3.8% | -4.2% | -8.3% | |
| – | 32.6% | – | – | – | – | – | – | – | – | – | – | – | |
| -1.5% | -5.4% | -3.6% | -5.5% | -2.0% | -0.1% | -0.1% | -1.3% | -0.5% | 0.0% | -0.2% | -0.7% | -0.3% | |
| -0.9% | 32.1% | – | – | – | -7.7% | -15.2% | -16.3% | -1.4% | -1.3% | -1.3% | -1.3% | -1.3% | |
| -2.4% | 27.3% | -66.2% | -0.4% | -2.9% | -9.4% | -15.3% | -17.4% | -1.8% | -1.1% | -1.5% | -1.8% | -1.6% | |
| -8.2% | 14.8% | -11.2% | -7.2% | 9.6% | -1.9% | 10.4% | -6.4% | -3.8% | -11.1% | 10.7% | -13.3% | -4.4% | |
| -3.9% | 14.7% | 3.9% | -7.3% | 12.8% | 11.7% | 29.6% | 11.3% | -2.4% | 3.9% | 11.8% | -9.1% | 1.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.